induces immune profile Th1/Th2/Th17 mixed immune profile peptide vaccine adjuvant CPDI-02 vaccine adjuvant 40 Joseph Vetro CPDI-02 Nilufer kosar https://www.ncbi.nlm.nih.gov/pubmed/?term=19836478 https://violinet.org/vaxjo/vaxjo_detail.php?c_vaxjo_id=154 vaccine adjuvant https://www.ncbi.nlm.nih.gov/pubmed/?term=11710544 Jie Zheng Oliver He https://github.com/vaccineontology/VO/issues/615 https://www.ncbi.nlm.nih.gov/pubmed/?term=20965299 A vaccine adjuvant that is a peptide which is able to induce Th1/Th2/Th17 immune responses through the mechanism of selectively activates C5aR1 on mononuclear phagocytes vs neutrophils. VAC: https://vac.niaid.nih.gov/view?id=40 Chemical Nature: Other - Peptide Mechanism of Action: (Primary) Selectively activates C5aR1 on mononuclear phagocytes vs neutrophils Immune profile induced: Th1/Th2/Th17 Route of immunization: IP, IV Point of Contact: Joseph Vetro, University of Nebraska Medical Center Wolfgang Leitner